Raza Mohammed Zain, Iqbal Beenish, Sundaralingam Anand, Addala Dinesh, Elsheikh Alguili, Hallifax Rob
Oxford Centre for Respiratory Medicine, Oxford University Hospitals NHS Trust, Oxford, UK.
St Peter's College, University of Oxford, Oxford, UK.
BMJ Open Respir Res. 2025 Jun 19;12(1):e003089. doi: 10.1136/bmjresp-2024-003089.
Primary spontaneous pneumothorax (PSP) occurs when air leaks into the pleural space in patients without known underlying lung disease, causing pain and breathlessness. Optimal management of PSP is not defined and we are unable to predict who will fail medical treatment (ongoing pneumothorax with prolonged air leak). We hypothesised that patients with longer symptom duration and higher symptom scores would be more likely to fail treatment.
Prospectively collected data from the Randomised Ambulatory Management of Primary Pneumothorax randomised controlled trial of ambulatory management were used to determine which clinical factors are associated with treatment failure including symptom scores, time from symptom onset to presentation, treatment allocation, vital signs, history of prior pneumothorax and size of initial pneumothorax.
Overall, 63/236 patients (26.7%) failed treatment. On average, symptoms started 1 day before admission. Multivariable analysis found that patients who presented at least 1 day after symptoms began had a lower risk of treatment failure than those presenting on the day symptoms began (ORs 0.39 (0.18 to 0.81)).
Further work is required to determine psychological drivers of PSP presentation and risks of prolonged air leak.
原发性自发性气胸(PSP)是指在无已知潜在肺部疾病的患者中,空气漏入胸膜腔,导致疼痛和呼吸困难。PSP的最佳治疗方案尚未明确,我们也无法预测哪些患者会治疗失败(持续气胸伴长时间漏气)。我们假设症状持续时间较长且症状评分较高的患者更有可能治疗失败。
前瞻性收集来自原发性气胸随机门诊管理随机对照试验的门诊管理数据,以确定哪些临床因素与治疗失败相关,包括症状评分、从症状出现到就诊的时间、治疗分配、生命体征、既往气胸病史和初始气胸大小。
总体而言,63/236例患者(26.7%)治疗失败。症状平均在入院前1天开始出现。多变量分析发现,症状开始后至少1天就诊的患者治疗失败风险低于症状开始当天就诊的患者(比值比0.39(0.18至0.81))。
需要进一步开展工作,以确定PSP发病的心理驱动因素和长时间漏气的风险。